Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Catalyst Pharmaceuticals, Inc. (CPRX) had Weighted-Average Shares Outstanding (Diluted) of 113.75M for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
$110.57M |
|
$34.84M |
|
$15.81M |
|
$94.76M |
|
$68.88M |
|
$41.69M |
|
$5.01M |
|
$46.71M |
|
$46.71M |
|
$34.84M |
|
$34.84M |
|
$34.84M |
|
$34.84M |
|
$41.69M |
|
$50.84M |
|
106.28M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
113.75M |
$0.32 |
|
$0.33 |
|
| Balance Sheet Financials | |
$219.33M |
|
$1.20M |
|
$250.78M |
|
$470.11M |
|
$76.06M |
|
-- |
|
$6.17M |
|
$82.23M |
|
$387.88M |
|
$193.83M |
|
$387.88M |
|
107.12M |
|
| Cash Flow Statement Financials | |
$143.60M |
|
$-293.50M |
|
$-10.86M |
|
$298.39M |
|
$137.64M |
|
$-160.76M |
|
$14.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.88 |
|
-- |
|
-- |
|
-- |
|
-- |
|
85.70% |
|
37.71% |
|
37.71% |
|
-- |
|
42.24% |
|
31.51% |
|
$143.37M |
|
-- |
|
-- |
|
-- |
|
0.24 |
|
1.01 |
|
2.07 |
|
43.56 |
|
8.98% |
|
17.98% |
|
7.41% |
|
8.98% |
|
$3.62 |
|
$1.26 |
|
$1.26 |
|